007370 — Jin Yang Pharmaceutical Co Cashflow Statement
0.000.00%
- KR₩63bn
- KR₩135bn
- KR₩113bn
Annual cashflow statement for Jin Yang Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 3,677 | 9,538 | 12,308 | 12,659 | 29,694 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -1,648 | 902 | -70.9 | -920 | -16,917 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2,111 | -10,622 | -7,081 | -5,861 | -2,009 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 6,245 | 1,971 | 7,448 | 8,534 | 12,792 |
| Capital Expenditures | -1,371 | -2,723 | -4,641 | -1,534 | -947 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 2,743 | -1,555 | -8,192 | 4,769 | -85,329 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 1,372 | -4,278 | -12,833 | 3,236 | -86,276 |
| Financing Cash Flow Items | 100 | 100 | -1,700 | -110 | 20 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -4,153 | 8,852 | -5,581 | -7,404 | 70,145 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3,464 | 6,544 | -10,966 | 4,365 | -3,338 |